SAMSUNG BIOLOGICS CO.,LTD.

207940 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩1,415,000.00
-0.56%
Delayed · cached 15 min

Fair value analysis

207940
SAMSUNG BIOLOGICS CO.,LTD.
Pharmaceuticals›Pharmaceuticals
₩1,415,000.00
Close used for this calculation
₩592,144.27Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
61/100
Profitability25/25
Returns9/25
Balance Sheet19/25
Efficiency8/25
Growth12/25
Good
Quality radar
61Prof.25/25Ret.9/25Eff.8/25B.Sht19/25Growth12/25

Consensus fair value

₩592,144.27
Above FV
▼ -58.2% against the close used
Model range ₩367,479.62 – ₩1,157,679.90
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩367,479.62Fair value₩592,144.27Bull₩1,157,679.90
FairClose
52-week traded range
52W low ₩1,243,000.0052W high ₩1,965,000.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

SAMSUNG BIOLOGICS CO.,LTD. closed at ₩1,415,000.00, 139.0% above the consensus fair value of ₩592,144.27 drawn from 8 valuation models.

Financial DNA score 61/100 — Good. P/E of 36.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩367,479.62
-74.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩374,072.55
-73.6%
√(22.5 × EPS × BVPS)
EPS=38589.33, BVPS=161161.73 · outside Graham range (P/E 36.7, P/B 8.8) — asset-light, treat as a rough floor
P/E Fair Value
₩771,786.60
-45.5%
EPS × 20x (sector P/E)
EPS=38589.33, Sector P/E=20x
Peter Lynch (PEG)
₩1,157,679.90
-18.2%
EPS × Growth% (PEG = 1 is fair)
EPS=38589.33, g=30%
EV/EBITDA
₩785,632.27
-44.5%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=2.07T
Book Value (P/B)
₩723,213.27
-48.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=161161.73, ROE=24%, g=6%, r=10%
Reverse DCF
₩1,415,000.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 15.3% | Historical: 49.3%
Margin of Safety
₩378,334.69
-73.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=504446.26, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.